Streetbeat News

Stock Prices

EL

Estee Lauder shares are trading lower after the company reported Q4 financial results and issued worse-than-expected Q1 and FY25 EPS outlook.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 11:13 am

ZIM

ZIM Integrated Shipping Services has increased its 2024 guidance, now expecting adjusted EBITDA of $2.6 billion to $3 billion, up from the prior range of $1.15 billion to $1.55 billion.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 11:08 am

ASPN

AU

UAMY

Three materials sector stocks, Aspen Aerogels Inc (ASPN), Anglogold Ashanti PLC (AU), and United States Antimony Corporation (UAMY), are showing overbought signals with high RSI values, indicating potential short-term price declines. Despite recent gains, investors should be cautious.

Portfolio Pulse from Avi Kapoor

August 19, 2024 | 11:07 am

CRGO

Freightos (NASDAQ:CRGO) reported a Q2 2024 adjusted EPS of $(0.05), beating the analyst consensus estimate of $(0.10) by 50%. This represents a 50% improvement over the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 11:05 am

RDHL

RedHill Biopharma Ltd. (NASDAQ:RDHL) announced positive preclinical results for its drug opaganib, showing potential benefits for weight gain and glucose tolerance in a high-fat diet model. This supports its potential use in treating Type 2 diabetes and obesity-related disorders.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 11:05 am

ZIM

ZIM Integrated Shipping (NYSE:ZIM) reported Q2 2024 earnings per share (EPS) of $3.08, significantly beating the analyst estimate of $1.66. The company also reported sales of $1.933 billion, surpassing the estimate of $1.799 billion. This marks a substantial improvement from the same period last year, with EPS increasing by 272.07% and sales by 47.56%.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 11:04 am

APGE

Apogee Therapeutics has started dosing healthy volunteers in its first clinical trial for APG990, a novel subcutaneous half-life extended monoclonal antibody targeting OX40L, initially developed for atopic dermatitis.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 11:02 am

TLSA

Tiziana Life Sciences has appointed Ivor Elrifi as its new CEO, effective immediately. Elrifi succeeds Gabriele Cerrone, who will continue as Executive Chairman and play a key role in the company's scientific agenda.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 11:01 am

EXK

Endeavour Silver Corp. (NYSE: EXK) has resumed operations at its Guanacevi mine following a ball mill failure. Temporary modifications have been made to maintain partial production, but output for 2024 is expected to be lower. The company anticipates a cash shortfall of less than $5 million over a 15-week period and has withdrawn its cost guidance for 2024.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 10:56 am

GLD

SPY

USO

UUP

On August 16th, U.S. stock markets closed higher with the S&P 500 and Nasdaq achieving their seventh consecutive session of gains. Positive economic indicators and optimism about potential Federal Reserve rate cuts lifted investor sentiment. Most S&P 500 sectors closed higher, led by financials, tech, and utilities. Asian markets showed mixed results, with Japan's Nikkei 225 closing lower while other major indices in the region rose. European markets opened in the green, and commodities saw varied movements with gold hitting a new high. The U.S. dollar weakened amid expectations of dovish signals from the Federal Reserve.

Portfolio Pulse from Akanksha Bakshi

August 19, 2024 | 10:54 am